Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Apply Now Explore your financing options or schedule a consultation to get started
Adjusted EBITDA : $66M (+23% YoY) Adjusted EBITDA Margin : 11% (flat YoY, -2pp QoQ) EPS : $0.08 (-27% YoY) Adjusted EBITDA Margin is also under pressure, down 5pp from its peak and 2pp QoQ
Among patients pretreated with one prior ROS1 TKI and no prior chemotherapy, the ORR was 38%
Use an alcohol swab to clean the injection spot, covering the entire area
No unnecessary appointments
US$ 20.15
US$ 20.74
US$ 29.17
US$ 26.51
US$ 21.29
US$ 24.33
US$ 29.90
US$ 28.15
US$ 26.45
